Russell Skibsted's Net Worth
$447 Thousand
Who is Russell Skibsted?
Russell Skibsted does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOTIME INC, Oncocyte Corp, Pharmagen, Inc., ROCKWELL MEDICAL, INC., AgeX Therapeutics, Inc., ALIMERA SCIENCES INC, Hana Biosciences Inc, AEOLUS PHARMACEUTICALS, INC., and Processa Pharmaceuticals, Inc..
SEC CIK
Russell Skibsted's CIK is 0001308105
Past Insider Trading and Trends
2023 was Russell Skibsted's most active year for acquiring shares with 4 total transactions. Russell Skibsted's most active month to acquire stocks was the month of August. 2018 was Russell Skibsted's most active year for disposing of shares, totalling 4 transactions. Russell Skibsted's most active month to dispose stocks was the month of September. 2017 saw Russell Skibsted paying a total of $5,284.80 for 252,000 shares, this is the most they've acquired in one year. In 2018 Russell Skibsted cashed out on 45,422 shares for a total of $16,652.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOTIME INC (LCTX) Snapshot price: $0.8778
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +157.27% | 14.72K |
$1.03 | -$8,014.43 | 24.08K |
Dec 18
| |||
Form 4
| +367.95% | 7.36K |
$2.22 | -$8,638.02 | 9.36K |
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
∞
| 2K |
$2.64 | $5,284.80 | 2K |
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncocyte Corp (OCX) Snapshot price: $2.89
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pharmagen, Inc. No price found
Former Executive Vice Pres.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ROCKWELL MEDICAL, INC. (RMTI) Snapshot price: $2.91
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AgeX Therapeutics, Inc. (AGE) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||